DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Sundry Debtors | ₹2,731 Cr | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr | ₹1,677 Cr |
What is the latest Sundry Debtors ratio of DIVIS LABORATORIES ?
Year | Sundry Debtors |
---|---|
Mar2025 | ₹2,731 Cr |
Mar2024 | ₹2,156 Cr |
Mar2023 | ₹1,793 Cr |
Mar2022 | ₹2,424 Cr |
Mar2021 | ₹1,677 Cr |
How is Sundry Debtors of DIVIS LABORATORIES Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2025 | ₹2,731 Cr | 26.67 | |
Mar2024 | ₹2,156 Cr | 20.25 | |
Mar2023 | ₹1,793 Cr | -26.03 | |
Mar2022 | ₹2,424 Cr | 44.58 | |
Mar2021 | ₹1,677 Cr | - |
Compare Sundry Debtors of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹162,864.3 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,478.0 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
CIPLA | ₹120,121.0 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
MANKIND PHARMA | ₹105,380.0 Cr | -0.6% | 5.1% | 31.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -7.1% |
-11.5% |
32.7% |
SENSEX | -1.2% |
-3.5% |
-0.5% |
You may also like the below Video Courses